RESOLUTE Trial Aims to Investigate the Value of Adding Local Ablative Treatment to Standard Systemic Treatment for Unresectable Oligometastatic Colorectal Cancer

NCT05862051 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

6

Enrollment

NETWORK

Sponsor class

Conditions

Colorectal Cancer
Oligometastatic Disease

Interventions

PROCEDURE: Local Ablative Therapy
PROCEDURE: Standard first-line systemic treatment

Sponsor

Australasian Gastro-Intestinal Trials Group

Collaborators

[object Object]
[object Object]